Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2)
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Phase I/II Study of Combination of Sorafenib, Vorinostat, and Bortezomib for the Treatment of Acute Myeloid Leukemia With Complex- or Poor-risk (Monosomy 5/7) Cytogenetics or FLT3-ITD Positive Genotype
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002)
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates
- Status
- COMPLETED
- Phase
- NA
Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020)
- Status
- COMPLETED
- Phase
- PHASE3
Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)
- Status
- TERMINATED
- Phase
- PHASE1
The Psychosocial and Economic Burden of Genital Warts
- Status
- COMPLETED
- Phase
- N/A
Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
- Status
- COMPLETED
- Phase
- N/A
The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Efficacy of MK-6096 for Migraine Prophylaxis in Participants With Episodic Migraine (MK-6096-020)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)
- Status
- COMPLETED
- Phase
- PHASE3
Treatment of Diabetes After Gastric Bypass With Sitagliptin
- Status
- COMPLETED
- Phase
- NA
Assessment of Pharmacokinetics of Single Dose Odanacatib (MK-0822) in Participants With Moderate Hepatic Insufficiency (MK-0822-070)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
- Status
- COMPLETED
- Phase
- PHASE2